Medicines Access Body Throws More Light On Global mRNA Vaccine Patent Filings
A new mapping exercise is intended to identify patents filed in relation to the mRNA technology transfer program set up to help lower-income countries build their own mRNA manufacturing facilities.
You may also be interested in...
As part of its drive to maximize global access to coronavirus vaccines, the Medicines Patent Pool has developed a publicly accessible resource giving information on the patent status of approved and candidate vaccines.
A European Parliament committee says that some aspects of the EU’s proposed unitary supplementary protection certificate scheme could promote access to cheaper off-patent medicines while others could delay generic competition.
The two countries want the European Commission’s proposals to be more closely examined for their possible negative effect on pharmaceutical investment decisions. The industry federation EFPIA says it is surprised more EU member states aren’t taking the same stance.